The 15-year outcomes of high-dose-rate brachytherapy for radical dose escalation in patients with prostate cancer-A benchmark for high-tech external beam radiotherapy alone?

The long-term results for the combination of HDR-BT and EBRT continue to show excellent results, providing high equivalent dose in 2 Gy per fraction and high disease control rates. These outcomes were reproducible for the extended follow-up period ranging up to 21.9 years.